Mayo Clinic - Recruiting 18 years or older. - Phase I Trial of Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS, With or Without Cyclophosphamide, in Patients With Recurrent or Refractory Multiple Myeloma.
MV-NIS; cyclophosphamide; I-123 prior MV-NIS; I-123 post MV-NIS; Liothyronine
National Cancer Institute (NCI) - Recruiting 18 years or older. - Phase II Trial of Twice Weekly Induction Followed by Once Weekly IV Velcade (Bortezomib) With Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Following at Least 1 Prior Therapy.
Southwest Oncology Group - Recruiting N/A or older. - S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients With Bone Metastases Starting Zoledronic Acid Treatment.